![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/13/2898133/0/en/Pasithea-Therapeutics-Announces-Completion-of-Enrollment-and-Initial-Dosing-of-Cohort-2-following-Positive-Safety-Review-Committee-SRC-Recommendation-for-PAS-004-in-Ongoing-Phase-1.html
https://www.globenewswire.com/news-release/2024/05/28/2888853/0/en/Pasithea-Therapeutics-to-Present-New-Preclinical-Data-Showing-PAS-004-Strongly-Inhibits-NRAS-Cancer-Cell-Lines-and-Demonstrates-Superior-Activity-in-Xenograft-Studies-at-2024-ASCO-.html
https://www.globenewswire.com/news-release/2024/04/29/2871159/0/en/Pasithea-Therapeutics-Announces-PAS-004-Abstract-Accepted-for-Poster-Presentation-at-2024-ASCO-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/24/2868521/0/en/Pasithea-Therapeutics-Announces-the-First-Cohort-has-Completed-the-Initial-Dosing-in-its-Phase-1-Trial-Evaluating-PAS-004-in-RAS-NF1-and-RAF-Mutated-Cancers.html
https://www.globenewswire.com//news-release/2024/01/08/2805360/0/en/Pasithea-Therapeutics-Announces-Invention-of-Crystalline-Form-of-PAS-004-Establishes-Strengthened-Intellectual-Property-IP-Position.html
https://www.globenewswire.com//news-release/2023/12/28/2801868/0/en/Pasithea-Therapeutics-Announces-Adjournment-of-Reconvened-Meeting-of-Stockholders-to-December-29-2023.html
https://www.globenewswire.com//news-release/2023/12/19/2798936/0/en/Pasithea-Therapeutics-Announces-Results-from-2023-Annual-Meeting.html
https://www.globenewswire.com//news-release/2023/12/11/2793833/0/en/Pasithea-Therapeutics-Announces-Positive-In-Vivo-Preclinical-Efficacy-Data-for-PAS-004-from-NRAS-Mutation-Cancer-Xenograft-Models.html
https://www.globenewswire.com//news-release/2023/09/14/2743251/0/en/Pasithea-Therapeutics-Corp-Announces-Final-Results-of-Tender-Offer.html
https://www.globenewswire.com//news-release/2023/09/07/2739785/0/en/Pasithea-Therapeutics-to-Participate-in-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html